INTERNATIONAL PRACTICES ON GMP IN PHARMACEUTICALS

Journal Title: Nature & Science - Year 2024, Vol 6, Issue 4

Abstract

Abstract Pharmaceutical science encompasses meticulous processes, from initial pharmacological testing to distribution and pharmacovigilance. Each stage demands unwavering precision and adherence to regulatory standards to ensure the quality and safety of medicinal products. This article delineates the multifaceted landscape of pharmaceutical regulations, focusing on Good Manufacturing Practice (GMP) standards as a cornerstone of quality assurance. GMP standards, encompassing GxP principles, mandate adherence to rigorous protocols throughout the drug lifecycle. Within the European Union (EU), GMP standards are codified in directives and regulations governing medicinal products for human and veterinary use. Volume 4 of Eudralex serves as a compendium of EU regulations, providing comprehensive guidelines for pharmaceutical manufacturing. Mutual Recognition Agreements on GMP inspections between the EU and other jurisdictions aim to facilitate trade and regulatory cooperation, exemplifying international collaboration in pharmaceutical oversight. Recent agreements between the EU and the US FDA streamline inspection processes, reducing redundant inspections and expediting market access for pharmaceutical products. Moreover, electronic systems such as EudraGMDP enhance transparency and regulatory compliance within the pharmaceutical industry. By evaluating international GMP practices, this article underscores the importance of harmonizing regulatory standards for Good Manufacturing Practices globally. In conclusion, adherence to GMP standards not only ensures the quality of pharmaceutical products but also plays a pivotal role in the development of pharmacy practices worldwide.

Authors and Affiliations

Rafael Abdullayev, Mahbuba Valiyeva, Tohfa Nasibova

Keywords

Related Articles

LEYŞMANİOZ XƏSTƏLİYİNİN ÖYRƏNİLMƏ TARİXİ, KLİNİKASI VƏ TÖRƏDİCİLƏRİN MORFOLOGİYASI

Xülasə Leyşmaniozların bütün formalarının əsas xüsusiyyəti onun sahibinin makrofaqal sisteminin xəstəliyi fonunda baş verməsi hesab edilir. Hünü sağlam insanı sancdıqdan bir neçə saat sonra inokulyasiya nahiyəsində ye...

REMOVAL OF A DUAL-SPECIES BIOFILM FROM ARTIFICIAL LATERAL CANALS

Lateral canals are particularly challenging to clean and disinfect. The aim of this study was to compare the removal efficacy of a dual-species biofilm from a lateral canal model by different ultrasonic irrigant activati...

Assessment of the Hazard Risk That May Arise During the Transportation of Hazardous Chemicals by Vehicle Transport

Abstract During our modern era, there are various types and numbers of chemically dangerous objects in the territory of our Republic, and they are constantly in operation. Thus, during the operation of these objects,...

EPIDEMIOLOGICAL FEATURES OF CYTOMEGALOVIRUS INFECTION

Abstract The article briefed on the epidemiological features of cytomegalovirus infection and shared the successes and experiences of studying these diseases in recent years. Cytomegaly is an infectious disease of vi...

THE SORPTION OF NON-FERROUS METAL-IONS BY CHELATING RESINS

Abstract Conditions of sorption equilibrium of copper, zinc, cadmium and lead-ions by chelatforming resins Amberlite IRC-748 and Duolite C 467 depending on the degree of neutralization of their ionogenic groups, the a...

Download PDF file
  • EP ID EP748681
  • DOI 10.36719/2707-1146/43/5-8
  • Views 31
  • Downloads 0

How To Cite

Rafael Abdullayev, Mahbuba Valiyeva, Tohfa Nasibova (2024). INTERNATIONAL PRACTICES ON GMP IN PHARMACEUTICALS. Nature & Science, 6(4), -. https://europub.co.uk/articles/-A-748681